{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:35:01Z","timestamp":1791048901863,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.jaad.2010.02.039","type":"journal-article","created":{"date-parts":[[2010,10,4]],"date-time":"2010-10-04T05:24:00Z","timestamp":1286169840000},"page":"984-990","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["A phase II placebo-controlled study of photodynamic therapy with topical hypericin and visible light irradiation in the treatment of cutaneous T-cell lymphoma and psoriasis"],"prefix":"10.1016","volume":"63","author":[{"given":"Alain H.","family":"Rook","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary S.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Duvic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric C.","family":"Vonderheid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Tobia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Cabana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2010.02.039_bib1","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-121-8-199410150-00007","article-title":"Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the S\u00e9zary syndrome)","volume":"121","author":"Bunn","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2010.02.039_bib2","first-page":"133","article-title":"Autologous bone marrow transplantation for advanced stage mycosis fungoides","volume":"7","author":"Bigler","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaad.2010.02.039_bib3","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/1097-0142(19930801)72:3<726::AID-CNCR2820720316>3.0.CO;2-P","article-title":"Prognostic implications of a bone marrow histopathologic classification system in mycosis fungoides and the S\u00e9zary syndrome","volume":"72","author":"Graham","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2010.02.039_bib4","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1172\/JCI108585","article-title":"The S\u00e9zary syndrome: a malignant proliferation of helper T cells","volume":"58","author":"Broder","year":"1976","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaad.2010.02.039_bib5","first-page":"725","article-title":"Report of the committee on staging and classification of cutaneous T-cell lymphomas","volume":"63","author":"Bunn","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.jaad.2010.02.039_bib6","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJM197412052912301","article-title":"Photochemotherapy of psoriasis and oral methoxsalen and long-wave ultraviolet light","volume":"219","author":"Parrish","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2010.02.039_bib7","first-page":"1","article-title":"Mechanism of photodynamic effects of furocoumarins","volume":"9","author":"Patapenko","year":"1991","journal-title":"J Photochem Photobiol"},{"key":"10.1016\/j.jaad.2010.02.039_bib8","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJM199704103361501","article-title":"Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet light A\u00a0radiation (PUVA): the PUVA follow-up study","volume":"336","author":"Stern","year":"1997","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jaad.2010.02.039_bib9","first-page":"47","volume":"55","author":"Thomas","year":"1992","journal-title":"Photoactivation of hypericin generates singlet oxygen in mitochondria and inhibits succinoxidase. Photochem Photobiol"},{"key":"10.1016\/j.jaad.2010.02.039_bib10","doi-asserted-by":"crossref","first-page":"5230","DOI":"10.1073\/pnas.85.14.5230","article-title":"Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: aromatic polycyclic diones hypericin and pseudohypericin","volume":"85","author":"Meruelo","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaad.2010.02.039_bib11","doi-asserted-by":"crossref","first-page":"5963","DOI":"10.1073\/pnas.86.15.5963","article-title":"Studies of the mechanism of action of the antiretroviral agents hypericin and pseudohypericin","volume":"86","author":"Lavie","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaad.2010.02.039_bib12","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1046\/j.1523-1747.1998.00278.x","article-title":"Photoactivated hypericin is an\u00a0anti-proliferative agent that induces a high rate of apoptotic death of normal, transformed, and malignant T\u00a0lymphocytes: implications for the treatment of cutaneous lymphoproliferative and inflammatory disorders","volume":"111","author":"Fox","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2010.02.039_bib13","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0190-9622(00)90209-3","article-title":"Photodynamic therapy in dermatology","volume":"42","author":"Kalka","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.02.039_bib14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jaad.2006.06.006","article-title":"Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus","volume":"56","author":"Braathen","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.02.039_bib15","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/jid.2008.309","article-title":"Low FAS\/CD95 expression by CTCL correlates with reduced sensitivity to apoptosis that can be restored by FAS upregulation","volume":"129","author":"Wu","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2010.02.039_bib16","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1182\/blood-2007-08-109074","article-title":"Resistance to FasL and tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in S\u00e9zary syndrome T-cells associated with impaired death receptor and FLICE-inhibitory protein expression","volume":"111","author":"Contassot","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2010.02.039_bib17","first-page":"8241","article-title":"Enhanced ubiquitinylation of heat shock protein 90 as a potential mechanism for mitotic cell death in cancer cells induced with hypericin","volume":"63","author":"Blank","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaad.2010.02.039_bib18","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1227\/00006123-199410000-00017","article-title":"Hypericin: a\u00a0potential antiglioma therapy","volume":"35","author":"Couldwell","year":"1994","journal-title":"Neurosurgery"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962210003051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962210003051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:20:11Z","timestamp":1759270811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962210003051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0190962210003051"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2010.02.039","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A phase II placebo-controlled study of photodynamic therapy with topical hypericin and visible light irradiation in the treatment of cutaneous T-cell lymphoma and psoriasis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2010.02.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}